Incidence and Relapse Triggers of Childhood Idiopathic Nephrotic Syndrome between 2006 and 2016: A Population-Based Study in Fukushima, Japan.


Journal

The Tohoku journal of experimental medicine
ISSN: 1349-3329
Titre abrégé: Tohoku J Exp Med
Pays: Japan
ID NLM: 0417355

Informations de publication

Date de publication:
02 2021
Historique:
entrez: 22 2 2021
pubmed: 23 2 2021
medline: 30 10 2021
Statut: ppublish

Résumé

Childhood idiopathic nephrotic syndrome (NS) is defined by proteinuria and hypoproteinemia. The incidence of childhood idiopathic NS varies with age, race, residential areas, and social conditions. In Japan, its incidence was estimated to be 6.49 cases/100,000 children. Our study aimed to investigate the incidence, characteristics, and rate of relapse of idiopathic NS in Fukushima between 2006 and 2016. Overall, 158 children aged from 6 months to 15 years old (65.8% male) developed idiopathic NS (median age at onset, 5.3 years). The peak age at onset was three years. The average annual incidence of childhood idiopathic NS was 5.16 (range, 3.47-9.26) cases/100,000 children. The highest incidence was in 2011, which was the year of the Great East Japan Earthquake and nuclear power plant accident, and reportedly caused psychological distress in the children at the time. Conversely, the five-year birth cohort showed minor difference from 2008 to 2012. The rate of incidence in males aged < 5 years was thrice greater than in females of the same age and almost the same for males and females aged 11-15 years. Of 507 total relapses in 115 NS children, common triggers of relapses were steroid discontinuation or reduction and infection. The average annual incidence of childhood NS based on the Fukushima population was lower than previously reported in Japan, and the annual incidence has changed over an 11-year period. These changes may be affected by social or environmental factors, including mental stress associated with lifestyle changes after the disaster.

Identifiants

pubmed: 33612573
doi: 10.1620/tjem.253.125
doi:

Substances chimiques

Steroids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

125-134

Auteurs

Yohei Kume (Y)

Department of Pediatrics, Fukushima Medical University.

Yukihiko Kawasaki (Y)

Department of Pediatrics, Fukushima Medical University.
Department of Pediatrics, Sapporo Medical University.

Kazuhide Suyama (K)

Department of Pediatrics, Fukushima Medical University.

Ryo Maeda (R)

Department of Pediatrics, Fukushima Medical University.

Yui Takahashi (Y)

Department of Pediatrics, Fukushima Medical University.

Masato Hoshino (M)

Department of Pediatrics, Fukushima Medical University.

Shigeo Suzuki (S)

Department of Pediatrics, Ohara General Hospital.

Masaki Mitomo (M)

Department of Pediatrics, Japanese Red Cross Society Fukushima Hospital.

Ruriko Nozawa (R)

Department of Pediatrics, Fujita General Hospital.

Yoshiyuki Namai (Y)

Department of Pediatrics, Ohta Nishinouchi General Hospital.

Hiroko Sakuma (H)

Department of Pediatrics, Hoshi General Hospital.

Masatoshi Kaneko (M)

Department of Pediatrics, Jusendo Hospital.

Shinichi Oda (S)

Department of Pediatrics, Iwase General Hospital.

Hiromichi Murai (H)

Department of Pediatrics, Shirakawa Kosei General Hospital.

Shuto Kanno (S)

Department of Pediatrics, Shirakawa Kosei General Hospital.

Katustoshi Nagasawa (K)

Department of Pediatrics, Takeda General Hospital.

Masaki Ito (M)

Department of Pediatrics, Soma General Hospital.

Hoshiro Suzuki (H)

Department of Pediatrics, Iwaki City Medical Center.

Shinichiro Ohara (S)

Department of Pediatrics, Iwaki City Medical Center.

Hayato Go (H)

Department of Pediatrics, Fukushima Medical University.

Aya Goto (A)

Center for Integrated Science and Humanities, Fukushima Medical University.

Mitsuaki Hosoya (M)

Department of Pediatrics, Fukushima Medical University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH